BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Varegacestat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Varegacestat\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07610005-10969@assetmemo.bio
DTSTAMP:20261121T004117Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:Varegacestat: Phase 1 readout est. (NCT07610005)
DESCRIPTION:Varegacestat\, phase 1.\nStudy: A Relative Bioavailability and 
 Bioequivalence Study of Varegacestat in Healthy Participants\nEstimated pr
 imary completion: May 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/varegacestat#upcoming-events\nRegistry record: https://clinicaltria
 ls.gov/study/NCT07610005
URL:https://assetmemo.bio/drug/varegacestat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
